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The end of season report provides a summary of South 
Carolina’s influenza surveillance components acquired through 
both mandatory and voluntary reporting procedures.  
Mandatory reporting elements consist of positive lab-confirmed 
tests (i.e. culture, RT-PCRs, DFAs, and IFAs), positive rapid antigen 
testing, and laboratory-confirmed hospitalizations and deaths.  
Voluntary reporting is accomplished by sentinel provider 
participation in the U.S. Outpatient Influenza-like Illness Network 
(ILINet). Data in this report is provisional. This report reflects 
data collected from October 1, 2017 to May 19, 2018 (MMWR 
Week 40- MMWR Week 20). 
 
Summary 
The 2017-18 influenza season was a severe season 
with widespread activity lasting for 11 consecutive 
weeks. The number of reported influenza infections, 
influenza-associated hospitalizations, and influenza-
associated deaths exceeded data reported during the 
same time period (MMWR week 40 to MMWR week 20) 
from the 2012-13 to 2016-17 seasons. Overall, 
influenza activity significantly increased during the 
week ending December 23, 2017 (MMWR week 51) and 
peaked during the weeks ending January 27, 2018 to 






















The percentage of reported circulating influenza 
viruses by type was 67.5% influenza A and 32.5% 
influenza B. Among lab-confirmed testing results, 
influenza A(not subtyped) was most frequently 
reported. Among influenza A viruses subtyped, 
influenza A(H3) was most frequently reported.  
Influenza B Yamagata was the predominantly reported 
influenza B virus when lineage was determined.  There 
were a total 3,575 positive lab-confirmed tests and 
131,570 positive rapid antigen detection tests reported 
during this time period.   
 
The percentage of outpatient visits attributed to an 
influenza-like illness was above the state baseline 
(3.13%) for 18 consecutive weeks. The intensity 
observed during the peak week (week ending February 
10) was 14.6%. The statewide cumulative influenza-
associated hospitalization rate and influenza-
associated mortality rate during this season was 90.5 
and 5.8 per 100,000, respectively.  Individuals aged 65 
and older were most afflicted this season, accounting 
for 57% of all influenza-associated hospitalizations and 
72% of all influenza-associated deaths. A total of 4,489 
hospitalizations and 289 deaths were reported.   
Upstate 






South Carolina 2017-18 Influenza End of Season  
Report and Surveillance Summary 
 






2017 pop estimate: 1.46 million  





2017 pop estimate: 1.17 million  





2017 pop estimate: 






*The number of reported influenza infections is dependent on 
the provider’s discretion to test or not test.  
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Virologic Surveillance: Lab-
Confirmed influenza 
Laboratory-confirmed results (e.g. culture, rt-PCR, DFA, 
and IFA) and positive rapid antigen test reporting 
provide surveillance data that aid in monitoring 
influenza trends at the county/regional/state level, 
identify type/subtype/lineage of influenza circulating, 
detect novel strains, determining geographic spread, 
and guiding vaccination efforts. Results are received 
from the DHEC Public Health Laboratories (PHL), 
commercial, and clinical laboratories. Of the 3,575 
positive influenza reports, PHL and commercial/clinical 
laboratories reported 241 (6.7%) and 3334 (93.3%) 
positive results, respectively. 
 
Influenza type A (n=2447; 68.4%) was most frequently 
reported by both PHL and commercial/clinical labs. Of 
those influenza A virus subtyped (n=744; 30.4%), 
influenza A(H3) accounted for 71.5% (n=532) of the 
specimens tested. Among influenza B viruses (n=1,128; 
31.6%) where lineage was performed, influenza B 
Yamagata (n=55; 96.5%) was most frequently reported. 
There were 19 co-infections of influenza reported of 
which 11 (57.9%) were A/B, 2 (10.5%) A(H3)/B, 5 (26.3%) 
















The number of lab-confirmed influenza results peaked 
during the weeks ending January 27 to February 10, 
2018. During the peak weeks, the total number of lab-
confirmed influenza reported ranged from 96 to                         
181. The median age of lab-confirmed influenza was 43 
years (IQR 11-67). Individuals aged 65 and older 
accounted for the majority of reports at 27.4% (n=980).  
Additionally, reported lab-confirmed influenza by age 
group were as follows: ages 0-4, 11.6% (n=417); ages 5 
to 17, 20.6% (n=737); ages 18 to 49, 22.7% (n=813); and 
ages 50 to 64, 17.6% (n=628). Influenza A (not 
subtyped) was most frequently reported among all age 
group.   
 
The largest percent of influenza B (lineage not 
determined) was noted in individuals aged 5 to 17.  The 
percent of influenza A to B was similar (71%-75% to 
25%-29%) for all age groups except for ages 5 to 17, 
where the percent of influenza A to B was 55% to 45%.  
Statewide females accounted for more lab-confirmed 














Lab-Confirmed Influenza Type by Age Group 
,oo 
Laboratory-Confirmed Influenza Reported by Clinical and Public Health 
Labs, 2017-18 Influenza Season 
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Surveillance data obtained from the reporting of 
influenza-associated hospitalizations aids in 
monitoring the epidemiology of severe influenza 
infections and assessing the severity of the season. 
Influenza-associated hospitalizations are reported 
weekly by age group. Laboratory confirmation (i.e. rt-
PCR, DFA, IFA, culture, or rapid antigen test) is a 
required component of the surveillance definition.  
During the 2017-18 season, a total of 4,489 influenza-
associated hospitalizations were reported. The highest 
number of hospitalizations (n=612) was reported 
during the week ending January 27. Moreover, during 
the same week hospitalizations peaked for individuals 
aged 0 to 4 and 65 and older. The peak weeks for other 
age groups are as follows: week ending February 3 for 





for ages 18 to 49, and week ending February 10 for 
ages 5 to 17. Of the 4,489 hospitalizations, 159 (3.5%) 
occurred in ages 0-4, 141 (3.1%) in ages 15-17, 584 
(13.0%) in ages 18-49, 1052 (23.4%) in ages 50-64, and  
and 2,553 (57.0%) in ages 65 and older.  
 
 
The overall statewide cumulative hospitalization rate 
during this period was 90.5 per 100,000 persons. The 
highest hospitalization rate of 404.0 per 100,000 was 
observed in individuals 65 years of age and older while 
the lowest rate, 17.5 was observed in the 5-17 year 
olds. In comparison to previous seasons, the 
cumulative hospitalization rate was higher overall and 
for all age groups this season except for individuals < 
18 years of age. In individuals aged 50 to 64, the 
hospitalization rate (115.5) was twice the average 











Influenza-associated deaths are defined as a death 
resulting directly or indirectly from a clinically 
compatible illness that was confirmed to be influenza 
by an appropriate laboratory or rapid diagnostic test 
or autopsy report. Additionally, there should be no 
period of complete recovery between the illness and 
death. This season, a total of 289 influenza-associated 
deaths were reported, of which 3 occurred in 
individuals < 18 years of age.  The highest number of 
deaths (n=44) was reported during the week ending 
January 27. The highest number of deaths reported by 
age group occurred in the following weeks: week 
ending February 24 for ages 0 to 4, weeks ending 
January 27 to February 3 for adults under 65, and 
weeks ending January 20 to January 27 for adults 65 
and older. There were no reported influenza-
associated deaths among individuals ages 5 to 17. 
Females (51%) accounted for more influenza-































2017-18 End of Season Report 
Influenza-Associated Deaths cont. 
The median age at time of death was 75 years (IQR 63-
86 years). Of the 289 deaths, 3 (1.0%) occurred in ages 
0-4, 27 (9.3%) in ages 18-49, 50 (17.3%) in ages 50-64, 
and 209 (72.4%) in ages 65 and older. The overall 
statewide cumulative mortality rate was 5.8 per 
100,000. The highest mortality rate of 33.1 per 100,000 
was reported in individuals 65 and older.  In ages 0-4, 
18-49, and 50-64 the mortality rate was 1.0, 1.3, and 
5.5, respectively.  
 
Influenza A and influenza B contributed to 75.6% and 
24.4% of deaths reported, respectively. Of the 
influenza A viruses subtyped, 17.3% were influenza 
A(H3).  The median time from illness onset to death 
was 7 days (IQR 3-13 days). When comparing age 
groups, the median time from illness onset to death in 
ages 18 to 49 was 5 days (IQR 2-8 days);  2 days shorter 
than reported in ages 50 to 64 and 65 and older at 7 
days (IQR 4-12 and IQR 3-14, respectively).   
Approximately, 93% of influenza-associated deaths 
were reported to have been diagnosed with one or 
more comorbidities. The most commonly reported 
pre-existing medical condition was cardiac disease 
(75%). 
 
Influenza vaccination history was collected on all 
reported deaths. Data sources for influenza 
vaccination history included: immunization record, 
medical record, immunization registry, or 
parent/family member report.  Of the 289 deaths, 139 
(48.1%) individuals had received this season’s flu 
vaccine and 150 (51.9%) individuals either had not 
been vaccinated or vaccination history was unknown.
 
 
 
